The study findings suggest VaL may be a non-toxic and effective second-line therapy that offers a prolongation of overall survival as well as fewer disease-related symptoms for patients with locally advanced or metastatic pancreatic cancer.

 

Further research on non-toxic and effective cancer therapies is warranted.

 

Study Pancreatic cancer

 

 

 

 

 

 

Menu